Veterinary Vaccines - Global Strategic Business Report

The global market for Veterinary Vaccines is estimated at US$9.9 Billion in 2023 and is projected to reach US$14.6 Billion by 2030, growing at a CAGR of 5.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the veterinary vaccines market is driven by several factors, including increasing pet ownership and the rising demand for animal-derived food products. As more people consider pets part of their family, there is a greater willingness to invest in preventive healthcare, including vaccinations. In the agricultural sector, the intensification of livestock farming and the need to ensure food safety and security drive the demand for effective vaccines to prevent disease outbreaks. Technological advancements that lead to the development of more effective and convenient vaccines also contribute to market expansion.

Moreover, heightened awareness of zoonotic diseases and the role of veterinary vaccines in preventing these infections promote the adoption of vaccination programs. Regulatory support and initiatives to control and eradicate animal diseases further stimulate market growth, ensuring that veterinary vaccines remain a critical component of animal healthcare and public health initiatives.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Porcine Vaccines segment, which is expected to reach US$4.7 Billion by 2030 with a CAGR of a 6.7%. The Poultry Vaccines segment is also set to grow at 5.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $2.6 Billion in 2023, and China, forecasted to grow at an impressive 5.3% CAGR to reach $2.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Veterinary Vaccines Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Veterinary Vaccines Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Veterinary Vaccines Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Bayer de México SA de CV, Biogénesis Bagó SA, Boehringer Ingelheim International GmbH, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 22 Featured):

• Bayer de México SA de CV
• Biogénesis Bagó SA
• Boehringer Ingelheim International GmbH
• Ceva Santé Animale
• Elanco Animal Health
• Heska Corporation
• Indian Immunologicals Ltd.
• Merck Animal Health
• Virbac SA
• Zoetis Inc.